KCM
INBX icon

Kennedy Capital Management’s Inhibrx INBX Stock Holding History

Kennedy Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,812
Closed -$4.9M – 565
2026
Q1 		$4.9M Buy
72,812
+1,324
+2% +$98.2K 0.1% 300
2025
Q4 		$5.65M Sell
71,488
-90,421
-56% -$6.16M 0.12% 274
2025
Q3 		$5.45M Sell
161,909
-15,409
-9% -$379K 0.12% 281
2025
Q2 		$2.53M Buy
177,318
+12,342
+7% +$160K 0.06% 410
2025
Q1 		$2.31M Sell
164,976
-705
-0.4% -$9.57K 0.06% 416
2024
Q4 		$2.55M Sell
165,681
-391
-0.2% -$5.96K 0.06% 474
2024
Q3 		$2.6M Buy
166,072
+1,101
+0.7% +$15.5K 0.06% 465
2024
Q2 		$2.34M Buy
+164,971
New +$2.58M 0.05% 488

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Kennedy Capital Management's INBX Position: Q2 2026 in Review

Kennedy Capital Management sold out of Inhibrx (INBX) in Q2 2026, closing a stake of 72,812 shares — an estimated $4.9M sold.

Kennedy Capital Management first reported a position in INBX in Q2 2024 and held it in 8 quarters. The position peaked at $5.65M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Kennedy Capital Management reported no remaining Inhibrx position as of Q2 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 72,812 Inhibrx shares in Q2 2026, an estimated $4.9M.
  • Kennedy Capital Management first reported a position in Inhibrx in Q2 2024 and held it in 8 quarters.
  • Kennedy Capital Management's Inhibrx position peaked at $5.65M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.